Ectopic USP15 expression inhibits HIV-1 transcription involving changes in YY1 deubiquitination and stability

Front Cell Infect Microbiol. 2024 Nov 18:14:1371655. doi: 10.3389/fcimb.2024.1371655. eCollection 2024.

Abstract

Introduction: Protein homeostasis is maintained by the opposing action of ubiquitin ligase and deubiquitinase, two important components of the ubiquitin-proteasome pathway, and contributes to both normal physiological and pathophysiological processes. The current study aims to delineate the roles of ubiquitin-specific protease 15 (USP15), a member of the largest deubiquitinase family, in HIV-1 gene expression and replication.

Methods: We took advantage of highly selective and specific ubiquitin variants (UbV), which were recently designed and developed for USP15, and ascertained the inhibitory effects of USP15 on HIV-1 gene expression and production by transfection and Western blotting. We also used real-time RT-PCR, transcription factor profiling, subcellular fractionation, immunoprecipitation followed by Western blotting to determine the transcription factors involved and the underlying molecular mechanisms.

Results: We first confirmed the specificity of USP15-mediated HIV-1 gene expression and virus production. We then showed that the inhibition of HIV-1 production by USP15 occurred at the transcription level, associated with an increased protein level of YY1, a known HIV-1 transcription repressor. Moreover, we demonstrated that USP15 regulated YY1 deubiquitination and stability. Lastly, we demonstrated that YY1 siRNA knockdown significantly diminished the inhibition of USP15 on HIV-1 gene expression and virus production.

Conclusion: These findings together demonstrate that stabilization of YY1 protein by USP15 deubiquitinating activity contributes to USP15-mediated inhibition of HIV-1 transcription and may help the development of USP15-specific UbV inhibitors as an anti-HIV strategy.

Keywords: HIV-1 transcription; USP15; YY1 protein stability; deubiquitination; transcription factors; ubiquitin variant inhibitors.

MeSH terms

  • Cell Line
  • Gene Expression Regulation, Viral
  • HEK293 Cells
  • HIV-1* / genetics
  • Host-Pathogen Interactions
  • Humans
  • Protein Stability
  • Transcription, Genetic
  • Ubiquitin-Specific Proteases* / genetics
  • Ubiquitin-Specific Proteases* / metabolism
  • Ubiquitination*
  • Virus Replication*
  • YY1 Transcription Factor* / genetics
  • YY1 Transcription Factor* / metabolism

Substances

  • USP15 protein, human
  • YY1 Transcription Factor
  • Ubiquitin-Specific Proteases
  • YY1 protein, human

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported in part by grants NIH/NIDA R01DA043162 and R01DA060761 and NIH/NINDS R01NS094108 (JH) from the National Institutes of Health and startup funds from Rosalind Franklin University.